stella
beta
A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy — Stella
Home
/
Obstructive Hypertrophic Cardiomyopathy
/
A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
View on ClinicalTrials.gov
Recruiting
Back to Obstructive Hypertrophic Cardiomyopathy trials
A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Trial locations
(2 sites)
South Korea
Local Institution - 0001, Seoul
Novotech Laboratory Korea Co., Ltd., Seoul